Rheumatoid arthritis and cardiovascular disease

被引:243
|
作者
Crowson, Cynthia S. [1 ]
Liao, Katherine P. [2 ,3 ]
Davis, John M., III [1 ]
Solomon, Daniel H. [2 ,3 ]
Matteson, Eric L. [1 ]
Knutson, Keith L. [1 ]
Hlatky, Mark A. [4 ]
Gabriel, Sherine E. [1 ]
机构
[1] Mayo Clin, Rochester, MN USA
[2] Brigham & Womens Hosp, Boston, MA 02115 USA
[3] Harvard Univ, Sch Med, Boston, MA USA
[4] Stanford Univ, Sch Med, Stanford, CA 94305 USA
基金
美国国家卫生研究院;
关键词
IMPROVES ENDOTHELIAL FUNCTION; NONCARDIAC VASCULAR-DISEASE; T-CELLS; GASTROINTESTINAL TOXICITY; MYOCARDIAL-INFARCTION; SECONDARY PREVENTION; ARTERIAL STIFFNESS; TELOMERIC LOSS; HEART-FAILURE; LIPID PROFILE;
D O I
10.1016/j.ahj.2013.07.010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Rheumatic disease and heart disease share common underpinnings involving inflammation. The high levels of inflammation that characterize rheumatic diseases provide a "natural experiment" to help elucidate the mechanisms by which inflammation accelerates heart disease. Rheumatoid arthritis (RA) is the most common of the rheumatic diseases and has the best studied relationships with heart disease. Methods A review of current literature on heart disease and RA was conducted. Results Patients with RA have an increased risk of developing heart disease that is not fully explained by traditional cardiovascular risk factors. Therapies used to treat RA may also affect the development of heart disease; by suppressing inflammation, they may also reduce the risk of heart disease. However, their other effects, as in the case of steroids, may increase heart disease risk. Conclusions Investigations of the innate and adaptive immune responses occurring in RA may delineate novel mechanisms in the pathogenesis of heart disease and help identify novel therapeutic targets for the prevention and treatment of heart disease.
引用
收藏
页码:622 / +
页数:8
相关论文
共 50 条
  • [21] Genetic Markers of Cardiovascular Disease in Rheumatoid Arthritis
    Rodriguez-Rodriguez, Luis
    Lopez-Mejias, Raquel
    Garcia-Bermudez, Mercedes
    Gonzalez-Juanatey, Carlos
    Gonzalez-Gay, Miguel A.
    Martin, Javier
    [J]. MEDIATORS OF INFLAMMATION, 2012, 2012
  • [22] Atherosclerotic cardiovascular disease in rheumatoid arthritis.
    del Rincón I.
    Escalante A.
    [J]. Current Rheumatology Reports, 2003, 5 (4) : 278 - 286
  • [23] Reducing the cardiovascular disease burden in rheumatoid arthritis
    Van Doornum, S
    Jennings, GLR
    Wicks, IP
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 2006, 184 (06) : 287 - 290
  • [24] Is rheumatoid arthritis a risk factor for cardiovascular disease?
    Mariana J Kaplan
    [J]. Nature Clinical Practice Rheumatology, 2007, 3 : 260 - 261
  • [25] Is rheumatoid arthritis a risk factor for cardiovascular disease?
    Kaplan, Mariana J.
    [J]. NATURE CLINICAL PRACTICE RHEUMATOLOGY, 2007, 3 (05): : 260 - 261
  • [26] Is Rheumatoid Arthritis a Causal Factor in Cardiovascular Disease?
    Bridges, S. Louis
    Niewold, Timothy B.
    Merriman, Tony R.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2022, 74 (10) : 1612 - 1614
  • [27] Atherosclerotic cardiovascular disease prevention in rheumatoid arthritis
    Semb, Anne Grete
    Ikdahl, Eirik
    Wibetoe, Grunde
    Crowson, Cynthia
    Rollefstad, Silvia
    [J]. NATURE REVIEWS RHEUMATOLOGY, 2020, 16 (07) : 361 - 379
  • [28] Management of Cardiovascular Disease Risk in Rheumatoid Arthritis
    Dessein, Patrick H.
    Gonzalez-Gay, Miguel A.
    [J]. JOURNAL OF CLINICAL MEDICINE, 2022, 11 (12)
  • [29] Atherosclerotic cardiovascular disease prevention in rheumatoid arthritis
    Anne Grete Semb
    Eirik Ikdahl
    Grunde Wibetoe
    Cynthia Crowson
    Silvia Rollefstad
    [J]. Nature Reviews Rheumatology, 2020, 16 : 361 - 379
  • [30] Cardiovascular disease and subclinical atherosclerosis in rheumatoid arthritis
    Suad Hannawi
    Haifa Hannawi
    Issa Al Salmi
    [J]. Hypertension Research, 2020, 43 : 982 - 984